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Polyarteritis nodosum (PAN) is a vasculitic disease that affects small to medium arteries. It often presents as a systemic
and multiorgan disease that affects the skin, joints, gastrointestinal tract, kidneys, and nervous system. Nonspecific signs
and symptoms are the hallmarks of PAN. It rarely affects single vessels, although there have been case reports of PAN
involving single intra-abdominal vessels. The authors present a case of a 42-year-old white man who presented with mild
epigastric pain but was otherwise asymptomatic. The workup ultimately revealed a rare case of an isolated celiac artery
aneurysm with a concomitant stenosis of the splenic artery secondary to PAN. The patient was treated with high-dose
steroid therapy, with resultant resolution of the vasculitis and a decreased size of the aneurysm. (J Vasc Surg 2006;44:
647-50.)Polyarteritis nodosum (PAN) is a vasculitis of small to
medium-sized arteries presenting as a systemic and multi-
organ disease. The skin, joints, gastrointestinal tract, kid-
neys, and nervous system are often simultaneously affected
by PAN. Depending on the organ system involved, the
nonspecific signs or symptoms on presentation make for a
difficult clinical diagnosis. PAN does not characteristically
affect single vessels, although there have been sporadic
reports of single intra-abdominal vessel involvement. The
patient presented in the following report is an example of
such a case.
CASE REPORT
A previously healthy 42-year-old white man presented to
the emergency room complaining of a 6-day history of abdom-
inal pain. The pain was described as constant, stabbing, nonra-
diating, and gradually increasing in intensity. There were no
precipitating or relieving factors. The patient denied any history
of drinking, smoking, or alcohol or drug abuse. The review of
systems was noncontributory. He was afebrile with minimal
tenderness on abdominal palpation. The rest of the physical
examination was unremarkable. No skin, mucosal, or joint
pathology was noted. A complete blood count, chemistry pro-
file, liver function tests, and amylase/lipase tests were per-
formed, and all results were within normal limits. A computed
tomography (CT) examination of the abdomen and pelvis re-
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tion of the spleen (Fig 1). This was followed by magnetic
resonance angiography of the aorta and its branches, and this
showed occlusion of the proximal splenic artery and stenosis of
the celiac axis. The left gastric and hepatic arteries were patent.
No other aneurysms were noted. Transesophageal echocardiog-
raphy did not demonstrate a cardiac source for emboli. The
rheumatology service was consulted for a provisional diagnosis
of celiac artery vasculitis. During his hospital stay, the patient’s
symptoms gradually resolved without intervention, and he was
discharged home on aspirin with plans for outpatient manage-
ment with close follow-up. High-dose steroid therapy was
considered at this time, but given the paucity of his symptoms,
the patient and the services involved agreed to proceed with
close observation and intervention on an outpatient basis if
needed.
The patient did well at home until the abdominal pain
recurred 1 week after discharge; this time it was accompanied by
a low-grade fever and vomiting. A complete physical examina-
tion was repeated with a specific search for lesions of the skin,
joints, and mucosa. No abnormalities were found. A full labo-
ratory evaluation was significant only for an erythrocyte sedi-
mentation rate of three times the normal upper limit and
proteinuria on urinalysis. Blood cultures, urinalysis, and a chest
radiograph were negative for any source of possible infection.
CT scan of the abdomen and pelvis showed progression of the
splenic infarction, with persistence of the inflammatory process
at the level of the celiac axis (Fig 2). The next day, an angiogram
of the aorta and renal vasculature was performed, in the hopes
that this would best visualize the celiac artery and the renal
vasculature. It revealed an aneurysm of the celiac artery measur-
ing approximately 3 cm and occlusion of the splenic artery (Fig
3). The renal arteries were unremarkable bilaterally. The rheu-
matology service again evaluated the patient and began high-
dose steroid therapy for a working diagnosis of polyarteritis
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sedimentation rate with proteinuria and the probable vasculitis
of the celiac artery seen on the previous CT scan. The patient’s
symptoms rapidly resolved after the onset of therapy. He was
discharged home several days later on oral steroid therapy and
with a plan for possible celiac artery aneurysm coil embolization
Fig 1. Inflammation completely surrounding the celiac artery is
noted on computed tomographic scan. An infarction secondary to
splenic artery stenosis can be seen at the lower pole of the spleen.
Fig 2. A repeat computed tomographic scan of the abdomen
shows persistence of the inflammation surrounding the celiac
artery.in the event the aneurysm increased in size. A follow-up CT scan2 weeks later revealed resolution of the surrounding inflamma-
tion of the celiac artery and stabilization of the aneurysm size.
The patient was seen several times as an outpatient with no
reports of abdominal pain. A CT scan 6 weeks after discharge
revealed further resolution of the inflammation and a slight
decrease in the size of the aneurysm (Fig 4).
DISCUSSION
Given this patient’s presentation and the results of his
evaluation, vasculitis of the celiac artery due to a connective
tissue disorder was the most likely explanation for his
symptoms and laboratory imaging abnormalities. Of the
vasculitic diseases, PAN seemed to fit the overall clinical
picture best, although this could not be confirmed conclu-
sively given the inaccessibility of the area to obtain a biopsy
specimen. Among the many types of vasculitic diseases, the
differential diagnoses to consider in this patient were
mainly those involving the medium to large arteries in
adults predisposed to aneurysm formation. Diseases that fit
these criteria, aside from PAN, include mycotic aneurysms,
Takayasu arteritis, and nonspecific arteritis. Our patient did
not present with septic symptomatology and denied any
behavior or history that would predispose him to systemic
infections. This made a mycotic aneurysm unlikely. Nega-
tive blood cultures and an unremarkable transesophageal
echocardiogram confirmed this as well. Takayasu arteritis
was also highly unlikely in our patient given its rarity
(2.6-6.4 cases per 1,000,000 population), geography
(mainly southeast Asians), sex (80%-90% female), and age
(15% of cases in individuals 40 years).1,2 A nonspecific
arteritis of the celiac artery was a possibility; however, the
proteinuria on urinalysis suggested a systemic disease de-
spite the negative renal angiogram. After analysis of the list
of possible etiologies, PAN seemed to be the most plausible
explanation.
PAN is a vasculitic disease that affects the small and
medium arteries.3 It causes transmural necrotizing inflam-
mation of these arteries. The inflammatory process can
cause weakening of the arterial wall, aneurysmal dilatation,
and possible rupture. In addition, the organs supplied by
these vessels can suffer impaired perfusion, resulting in
ulceration, infarcts, or ischemic atrophy. The exact patho-
genesis of PAN is unknown, but it is widely thought to be
the result of an immune process targeting blood vessels.4
PAN is a rare condition with a worldwide incidence of 0.7
in 100,000 and a prevalence of 6.3 in 100,000 in the
United States.5 It predominantly affects 40- to 60-year-old
individuals and has a higher incidence in men (the male-
female ratio is 1.6:1). There is no known racial predilec-
tion.5
The clinical manifestations of PAN vary widely from
benign cutaneous lesions to a fulminant, disseminated
form. The most common symptoms include fever, malaise,
and weight loss, present in 70% of patients. These are
followed closely by neurologic symptoms consisting mainly
of mononeuritis multiplex and polyneuropathy in 65% of
patients. The patient in this report presented initially with
abdominal pain only, which is seen in less than 40% of
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attributable to mesenteric arteritis and is especially intense
after meals.7
Individuals affected by PAN commonly display evi-
dence of nonspecific inflammatory changes during the ini-
tial laboratory evaluation. A complete blood count may
reveal a normochromic anemia, a polymorphonuclear leu-
kocytosis, or both. The erythrocyte sedimentation rate is
increased in most patients to greater than 60 mm/h. An
increased creatinine or proteinuria is a sign of kidney in-
volvement, whereas an increased creatinine phosphokinase
is an indicator of muscle involvement. Disease-specific lab-
oratory evaluation includes testing for antineutrophil cyto-
plasmic antibodies, because 20% of patients with PAN are
positive for perinuclear antineutrophilic cytoplasmic anti-
body. C3 and C4 serum complement levels are depressed in
25% of patients with PAN.8
Arteriography is the primary imaging modality used to
diagnose PAN. One of the most characteristic findings on
angiography is multiple saccular aneurysms resulting from
pannecrosis of the internal elastic lamina of the medium
and small arteries. These aneurysms tend to occur at
branching points of the affected arteries, with a predisposi-
tion for the kidneys and liver.9 Aneurysms are observed on
angiography in up to 94% of patients with known PAN.10
Other, less specific, findings on angiography include arterial
stenosis, thrombosis, and occlusion.11 The sensitivity and
specificity of angiography in the diagnosis of PAN is re-
ported to be 89% and 90%, respectively.10 Arterial occlu-
sions may result in end-organ damage from infarction and
are often first identified on CT scan during initial work-
up.12 Although angiography establishes the presence of
PAN in 80% of all patients with the disease, a negative
angiogram does not exclude the presence of PAN.13
Initial therapy consists of corticosteroids, and a re-
sponse is usually observed within the first 3 months.14
Prolonged steroid therapy is often required in those who
initially respond; this causes steroid dependence to keep the
disease in remission. As an alternative, cyclophosphamide
has been shown to induce long-term remissions in most
patients, including those who had no response to steroid
therapy.15 Patients with severe disease have been shown to
have an improved survival if a combination of corticoste-
roids and cyclophosphamide is used, as opposed to steroid
therapy alone.16
PAN that is untreated has a poor prognosis, with a
1-year survival rate of almost 50% and a 5-year survival rate
of less than 15%. If PAN is adequately treated, the 5-year
survival rate increases to almost 80%.16 Poor prognostic
factors include an increase in plasma creatinine to greater
than 1.5 mg/dL (indicating renal insufficiency secondary
to kidney involvement) and gastrointestinal involvement.17
Celiac artery aneurysms themselves are rare, and their
association with vasculitic syndromes is unknown. The
presence of a celiac artery aneurysm should be a cause for
concern because of reports of considerable mortality and
morbidity after aneurysm rupture.18 The incidence of rup-
ture has not been identified, but it is thought overall to below.19 Furthermore, because of its rarity, to our knowl-
edge, there has been no study as of yet that identifies the
population at risk for aneurysm formation and/or rupture
or that predicts which cases will rupture. There are no
definitive criteria regarding themanagement of celiac artery
aneurysms, but it has been suggested that aneurysms larger
than 2 cm in a healthy patient should undergo interven-
tion.20 Reported treatment options include aneurysm liga-
tion with revascularization, endovascular stenting, and en-
dovascular embolization. In the case presented, there was
Fig 3. The celiac artery aneurysm can be clearly seen on the
abdominal arteriogram. There is little, if any, involvement of the
kidney.
Fig 4. Significant resolution of the surrounding inflammation 6
weeks later with a slight decrease in aneurysm size (arrow). The
splenic infarction has not progressed.concern for increased complications with immediate inter-
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active inflammation surrounding the aneurysm. Once res-
olution of the inflammation was confirmed, the patient was
scheduled to undergo therapy for the aneurysm. Fortu-
nately, the aneurysm size decreased with steroid therapy
alone, thus circumventing the need for an invasive proce-
dure at this time.
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